BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23072860)

  • 1. Trials and tribulations in lupus anticoagulant testing.
    Favaloro EJ
    Clin Chem Lab Med; 2013 Feb; 51(2):253-6. PubMed ID: 23072860
    [No Abstract]   [Full Text] [Related]  

  • 2. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
    Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
    Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
    [No Abstract]   [Full Text] [Related]  

  • 3. Rivaroxaban and false positive lupus anticoagulant testing.
    Merriman E; Kaplan Z; Butler J; Malan E; Gan E; Tran H
    Thromb Haemost; 2011 Feb; 105(2):385-6. PubMed ID: 21103666
    [No Abstract]   [Full Text] [Related]  

  • 4. In ECAT veritas?
    Reber G; Meijer P
    Lupus; 2012 Jun; 21(7):722-4. PubMed ID: 22635212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of lupus anticoagulant during ongoing anticoagulation therapy].
    Kristoffersen AH; Jacobsen EM; Varsi K; Henriksson CE
    Tidsskr Nor Laegeforen; 2019 Oct; 139(15):. PubMed ID: 31642626
    [No Abstract]   [Full Text] [Related]  

  • 6. To do or not to do mixing study in the era of integrated testing for lupus anticoagulant.
    Ray D; Ahluwalia J; Hans C; Kler A; Kumar A; Kumar N
    Blood Coagul Fibrinolysis; 2024 Jun; 35(4):223-224. PubMed ID: 38709110
    [No Abstract]   [Full Text] [Related]  

  • 7. Lupus anticoagulant testing--sometimes mixing is required: potential for false negatives without mixing studies.
    Favaloro EJ; Bonar R; Marsden K
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):673-6. PubMed ID: 23912135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Improvement in the effectiveness of detection of lupus type anticoagulants by Echis toxin tests].
    Barkagan ZS; Serdiuk GV; Tsyvkina LP
    Klin Lab Diagn; 1994; (6):27-9. PubMed ID: 7894903
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there evidence for persistent or transient positive lupus anticoagulants according to the degree of prolongation of clotting tests?
    Devreese KM
    Thromb Res; 2008; 122(4):576-9. PubMed ID: 18304615
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of commercial normal pooled plasma used in the laboratory diagnosis of lupus anticoagulants.
    Coppens A; Devreese KM
    Thromb Res; 2010 Sep; 126(3):246-9. PubMed ID: 20106507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lupus anticoagulant (LA)].
    Gohchi K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():694-6. PubMed ID: 15658426
    [No Abstract]   [Full Text] [Related]  

  • 12. The "lupus" circulating anticoagulant, AKA the primary antiphospholipid syndrome.
    Rothschild BM
    Compr Ther; 1996 Jul; 22(7):420-3. PubMed ID: 8866192
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
    Jennings I; Kitchen S; Woods TA; Preston FE; Greaves M
    Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time.
    van Os GM; de Laat B; Kamphuisen PW; Meijers JC; de Groot PG
    J Thromb Haemost; 2011 Aug; 9(8):1657-9. PubMed ID: 21668740
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing.
    Wong RC; Adelstein S; Gillis D; Favaloro EJ
    Semin Thromb Hemost; 2005 Feb; 31(1):39-48. PubMed ID: 15706474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome.
    Devreese K; Hoylaerts MF
    Eur J Haematol; 2009 Jul; 83(1):1-16. PubMed ID: 19226362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays.
    Pradella P; Azzarini G; Santarossa L; Caberlotto L; Bardin C; Poz A; D'Aurizio F; Giacomello R
    Clin Chem Lab Med; 2013 Feb; 51(2):379-85. PubMed ID: 23001319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISTH guidelines on lupus anticoagulant testing.
    Pengo V
    Thromb Res; 2012 Oct; 130 Suppl 1():S76-7. PubMed ID: 23026672
    [No Abstract]   [Full Text] [Related]  

  • 19. When to screen for lupus anticoagulant? Influence of testing during acute phase and consequences for clinical practise.
    Ruinemans-Koerts J; Ahmed-Ousenkova YM; Kaasjager HA; Hendriks-van Wijhe C; Hovens MM
    Lupus; 2015 Oct; 24(11):1233-5. PubMed ID: 25914406
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti phospholipid syndrome.
    Housley E
    Eur J Vasc Endovasc Surg; 1995 Nov; 10(4):394-5. PubMed ID: 7489205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.